ALHC Financial Statements

Balance sheet, income statement, cash flow, and dividends for Alignment Healthcare Inc (ALHC).


$2.16B Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

ALHC Market Cap. (MRY)


ALHC Shares Outstanding (MRY)


ALHC Assets (MRY)


Total Assets

$782.06M

Total Liabilities

$681.11M

Total Investments

$37.79M

ALHC Income (MRY)


Revenue

$2.70B

Net Income

-$128.03M

Operating Expense

$398.17M

ALHC Cash Flow (MRY)


CF Operations

$34.77M

CF Investing

$39.19M

CF Financing

$156.03M

ALHC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

ALHC Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$782,063,000 (32.13%)

$591,880,000 (-6.62%)

$633,863,000 (0.47%)

$630,895,000 (86.38%)

Assets Current

$661,638,000 (36.83%)

$483,537,000 (-11.20%)

$544,546,000 (-1.50%)

$552,859,000 (108.88%)

Assets Non-Current

$120,425,000 (11.15%)

$108,343,000 (21.30%)

$89,317,000 (14.46%)

$78,036,000 (5.70%)

Goodwill & Intangible Assets

$39,376,000 (-1.75%)

$40,078,000 (-0.52%)

$40,288,000 (14.73%)

$35,116,000 (1.36%)

Shareholders Equity

$99,851,000 (-36.38%)

$156,946,000 (-34.09%)

$238,126,000 (-22.19%)

$306,040,000 (899.77%)

Property Plant & Equipment Net

$74,957,000 (21.17%)

$61,860,000 (43.88%)

$42,994,000 (12.52%)

$38,211,000 (3.18%)

Cash & Equivalents

$432,859,000 (113.33%)

$202,904,000 (-50.46%)

$409,549,000 (-12.23%)

$466,600,000 (125.07%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$308,000 (0%)

$0 (0%)

Total Investments

$37,791,000 (-67.40%)

$115,914,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$37,791,000 (-67.40%)

$115,914,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$153,904,000 (28.52%)

$119,749,000 (28.91%)

$92,890,000 (58.75%)

$58,512,000 (45.77%)

Trade & Non-Trade Payables

$311,914,000 (36.26%)

$228,910,000 (13.26%)

$202,115,000 (41.03%)

$143,317,000 (11.72%)

Accumulated Retained Earnings (Deficit)

-$1,008,293,000 (-14.55%)

-$880,258,000 (-20.21%)

-$732,241,000 (-25.66%)

-$582,694,000 (-53.51%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$329,263,000 (92.79%)

$170,787,000 (3.76%)

$164,600,000 (4.44%)

$157,595,000 (2.04%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$329,263,000 (92.79%)

$170,787,000 (3.76%)

$164,600,000 (4.44%)

$157,595,000 (2.04%)

Total Liabilities

$681,108,000 (57.01%)

$433,809,000 (9.95%)

$394,561,000 (21.46%)

$324,840,000 (5.50%)

Liabilities Current

$351,845,000 (33.77%)

$263,022,000 (14.38%)

$229,961,000 (37.50%)

$167,245,000 (8.99%)

Liabilities Non-Current

$329,263,000 (92.79%)

$170,787,000 (3.76%)

$164,600,000 (4.44%)

$157,595,000 (2.04%)

ALHC Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,703,561,000 (48.25%)

$1,823,630,000 (27.16%)

$1,434,159,000 (22.81%)

$1,167,773,000 (21.74%)

Cost of Revenue

$2,406,870,000 (48.33%)

$1,622,600,000 (29.82%)

$1,249,879,000 (20.29%)

$1,039,041,000 (31.03%)

Selling General & Administrative Expense

$371,374,000 (20.80%)

$307,433,000 (3.99%)

$295,646,000 (1.60%)

$290,991,000 (86.06%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$398,174,000 (21.40%)

$327,994,000 (4.76%)

$313,095,000 (2.13%)

$306,575,000 (78.01%)

Interest Expense

$23,547,000 (10.91%)

$21,231,000 (16.09%)

$18,289,000 (4.85%)

$17,443,000 (3.02%)

Income Tax Expense

$21,000 (195.45%)

-$22,000 (-106.49%)

$339,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$128,071,000 (13.57%)

-$148,173,000 (0.98%)

-$149,639,000 (23.37%)

-$195,286,000 (-751.81%)

Net Income to Non-Controlling Interests

-$36,000 (76.92%)

-$156,000 (-69.57%)

-$92,000 (0%)

$0 (0%)

Net Income

-$128,035,000 (13.50%)

-$148,017,000 (1.02%)

-$149,547,000 (23.42%)

-$195,286,000 (-751.81%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$128,035,000 (13.50%)

-$148,017,000 (1.02%)

-$149,547,000 (23.42%)

-$195,286,000 (-751.81%)

Weighted Average Shares

$190,793,552 (2.46%)

$186,214,784 (2.76%)

$181,212,757 (5.38%)

$171,956,849 (13.03%)

Weighted Average Shares Diluted

$190,793,552 (2.46%)

$186,214,784 (2.76%)

$181,212,757 (5.38%)

$171,956,849 (13.03%)

Earning Before Interest & Taxes (EBIT)

-$104,467,000 (17.62%)

-$126,808,000 (3.14%)

-$130,919,000 (26.39%)

-$177,843,000 (-2866.52%)

Gross Profit

$296,691,000 (47.59%)

$201,030,000 (9.09%)

$184,280,000 (43.15%)

$128,732,000 (-22.56%)

Operating Income

-$101,483,000 (20.07%)

-$126,964,000 (1.44%)

-$128,815,000 (27.57%)

-$177,843,000 (-2866.52%)

ALHC Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$39,191,000 (126.61%)

-$147,263,000 (-421.89%)

-$28,217,000 (-35.56%)

-$20,815,000 (-27.25%)

Net Cash Flow from Financing

$156,028,000 (148498.10%)

$105,000 (-99.37%)

$16,593,000 (-95.39%)

$360,130,000 (176.76%)

Net Cash Flow from Operations

$34,770,000 (158.75%)

-$59,187,000 (-30.29%)

-$45,427,000 (42.33%)

-$78,776,000 (-1141.87%)

Net Cash Flow / Change in Cash & Cash Equivalents

$229,989,000 (211.46%)

-$206,345,000 (-261.69%)

-$57,051,000 (-121.90%)

$260,539,000 (114.74%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$4,043,000 (-187.76%)

-$1,405,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$80,595,000 (172.43%)

-$111,268,000 (-27717.00%)

-$400,000 (61.90%)

-$1,050,000 (-40.00%)

Capital Expenditure

-$41,404,000 (-15.03%)

-$35,995,000 (-51.40%)

-$23,774,000 (-29.49%)

-$18,360,000 (-17.63%)

Issuance (Repayment) of Debt Securities

$156,208,000 (0%)

$0 (0%)

$16,625,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$155,000 (0%)

$0 (0%)

$0 (0%)

$360,115,000 (176.75%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$71,132,000 (6.43%)

$66,835,000 (-18.21%)

$81,718,000 (-26.11%)

$110,600,000 (5107.16%)

Depreciation Amortization & Accretion

$28,826,000 (20.18%)

$23,986,000 (18.18%)

$20,297,000 (8.17%)

$18,764,000 (5.55%)

ALHC Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

11.00% (0.00%)

11.00% (-14.06%)

12.80% (16.36%)

11.00% (-36.42%)

Profit Margin

-4.70% (41.98%)

-8.10% (22.12%)

-10.40% (37.72%)

-16.70% (-595.83%)

EBITDA Margin

-2.80% (50.00%)

-5.60% (27.27%)

-7.70% (43.38%)

-13.60% (-1233.33%)

Return on Average Equity (ROAE)

-109.20% (-43.50%)

-76.10% (-39.63%)

-54.50% (7.47%)

-58.90% (-161.80%)

Return on Average Assets (ROAA)

-18.10% (11.27%)

-20.40% (7.27%)

-22.00% (25.68%)

-29.60% (-244.19%)

Return on Sales (ROS)

-3.90% (44.29%)

-7.00% (23.08%)

-9.10% (40.13%)

-15.20% (-2433.33%)

Return on Invested Capital (ROIC)

-49.70% (41.18%)

-84.50% (41.32%)

-144.00% (9.60%)

-159.30% (-2242.65%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-16.79 (-54.06%)

-10.9 (23.08%)

-14.17 (-14.89%)

-12.33

Price to Sales Ratio (P/S)

0.79 (-9.67%)

0.88 (-40.85%)

1.49 (-28.21%)

2.07

Price to Book Ratio (P/B)

21.6 (108.19%)

10.37 (12.18%)

9.25 (7.51%)

8.6

Debt to Equity Ratio (D/E)

6.82 (146.78%)

2.76 (66.81%)

1.66 (56.17%)

1.06 (-89.45%)

Earnings Per Share (EPS)

-0.67 (15.19%)

-0.79 (4.82%)

-0.83 (27.19%)

-1.14 (-660.00%)

Sales Per Share (SPS)

14.17 (44.70%)

9.79 (23.74%)

7.91 (16.54%)

6.79 (7.71%)

Free Cash Flow Per Share (FCFPS)

-0.04 (93.15%)

-0.51 (-33.77%)

-0.38 (32.39%)

-0.56 (-966.04%)

Book Value Per Share (BVPS)

0.52 (-37.96%)

0.84 (-35.84%)

1.31 (-26.18%)

1.78 (785.57%)

Tangible Assets Book Value Per Share (TABVPS)

3.89 (31.39%)

2.96 (-9.55%)

3.28 (-5.45%)

3.46 (73.51%)

Enterprise Value Over EBIT (EV/EBIT)

-19 (-72.73%)

-11 (21.43%)

-14 (-7.69%)

-13

Enterprise Value Over EBITDA (EV/EBITDA)

-26.92 (-96.69%)

-13.69 (15.87%)

-16.27 (-13.09%)

-14.39

Asset Turnover

3.83 (52.71%)

2.51 (19.14%)

2.1 (18.86%)

1.77 (-50.89%)

Current Ratio

1.88 (2.29%)

1.84 (-22.38%)

2.37 (-28.37%)

3.31 (91.65%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$6,634,000 (93.03%)

-$95,182,000 (-37.54%)

-$69,201,000 (28.76%)

-$97,136,000 (-1107.11%)

Enterprise Value (EV)

$2,036,471,046 (44.70%)

$1,407,419,166 (-21.80%)

$1,799,878,137 (-21.36%)

$2,288,842,852

Earnings Before Tax (EBT)

-$128,014,000 (13.53%)

-$148,039,000 (0.78%)

-$149,208,000 (23.60%)

-$195,286,000 (-751.81%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$75,641,000 (26.44%)

-$102,822,000 (7.05%)

-$110,622,000 (30.46%)

-$159,079,000 (-1450.07%)

Invested Capital

$287,246,000 (11.92%)

$256,663,000 (116.29%)

$118,665,000 (-0.72%)

$119,529,000 (22.55%)

Working Capital

$309,793,000 (40.49%)

$220,515,000 (-29.90%)

$314,585,000 (-18.42%)

$385,614,000 (246.70%)

Tangible Asset Value

$742,687,000 (34.59%)

$551,802,000 (-7.04%)

$593,575,000 (-0.37%)

$595,779,000 (96.07%)

Market Capitalization

$2,156,581,046 (32.46%)

$1,628,149,166 (-26.07%)

$2,202,189,137 (-16.35%)

$2,632,617,852

Average Equity

$117,259,250 (-39.73%)

$194,562,500 (-29.07%)

$274,311,000 (-17.23%)

$331,429,250 (1478.08%)

Average Assets

$705,959,500 (-2.89%)

$726,992,250 (6.72%)

$681,199,250 (3.32%)

$659,305,500 (147.88%)

Invested Capital Average

$210,394,000 (40.27%)

$149,992,000 (64.93%)

$90,944,250 (-18.53%)

$111,632,000 (25.98%)

Shares

191,696,093 (1.37%)

189,099,787 (0.98%)

187,260,981 (0.01%)

187,241,668 (-0.02%)